Jump to content
RemedySpot.com

031201b

Rate this topic


Guest guest

Recommended Posts

Guest guest

[Federal Register: March 12, 2001 (Volume 66, Number 48)]

[Notices] [Page 14390-14391]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr12mr01-80] -----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. 00M-1640, 00M-1664, 00M-1591, 00M-1613, 00M-1597, 00M-

1593, 00M-1583, 00M-1615, 00M-1612, 00M-1569, 00M-1658, 00M-1570, 00M-

1616, 00M-1659, 00M-1649, 00M-1650, 00M-1660, 00M-1661, 00M-1683, 00M-

1684]

Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMA's) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMA's through the Internet and the agency's Dockets Management Branch.

ADDRESSES: Submit a written request for copies of summaries of safety and effectiveness to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT: Thinh X. Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186.

SUPPLEMENTARY INFORMATION:

I. Background

In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule to revise Secs. 814.44(d) and 814.45(d) (21 CFR 814.44(d) and 814.45(d)) to discontinue publication of individual PMA approvals and denials in the Federal Register. Instead, revised Secs. 814.44(d) and 814.45(d) state that FDA will notify the public of PMA approvals and denials by posting them on FDA's home page at http://

www.fda.gov on the Internet; by placing the summaries of safety and effectiveness on the Internet and in FDA's Dockets Management Branch; and by publishing in the Federal Register after each quarter a list of available safety and effectiveness summaries of approved PMA's and denials announced in that quarter.

FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.

In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under Sec. 10.33(B) (21 CFR 10.33(B)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(B) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The following is a list of approved PMA's for which summaries of safety and effectiveness were placed on the Internet in accordance with the procedure explained previously from October 1, 2000, through December 31, 2000. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

Table 1.--List of Safety and Effectiveness Summaries for Approved PMA's

Made Available October 1, 2000, Through December 31, 2000

------------------------------------------------------------------------

PMA Number/

Docket No. Applicant Trade Name Approval Date

------------------------------------------------------------------------

P970053/00M- Nidek EC-5000 Excimer Laser December 17,

1640 Technologies, System 1998

Inc.

P970053(S1)/ Nidek EC-5000 Excimer Laser September 29,

00M-1664 Technologies, System (PARK) 1999

Inc.

P930034(S13)/ Summit SVS Apex Plus Excimer October 21,

00M-1591 Technologies Laser Workstation 1999

P990019/00M- DUSA BLU-U Light Photodynamic December 3,

1613 Pharmaceuticals Therapy Illuminator 1999

, Inc.

[[Page 14391]]

P990027/00M- Bausch & Lomb Technolas 217 February 23,

1597 Surgical, Inc. Excimer Laser System 2000

P970043(S5)/ Autonomous LADAR Vision May 9, 2000

00M-1593 Technologies Excimer Laser System

Corp.

P990052/00M- Symphonix Vibrant P/Vibrant D August 31,

1583 Devices, Inc. Soundbridge System 2000

P980010/00M- Osteometer DTU-One Ultrasound September 19,

1615 MediTech, Inc. Scanner 2000

P970043(S7)/ Autonomous LADAR Vision September 22,

00M-1612 Technologies Excimer Laser System 2000

Corp.

P990040/00M- Cordis Trufill N-Butyl September 25,

1569 Neurovascular, Cyanoacrylate Liquid 2000

Inc. Embolic System

P000014/00M- Ortho-Clinical VITROS Immunodiagnostic September 29,

1658 Diagnostics, Anti-HBS Reagent Pack 1999

Inc. and Calibrators

P990046/00M- ATS Medical, ATS Open Pivot October 13,

1570 Inc. Bileaflet Heart Valve 2000

N18286(S12)/ Pharmacia & Gelfoam October 16,

00M-1616 Upjohn Co. Sterile Powder 2000

P000015/00M- Cochlear Corp. Nucleus 24 Auditory October 20,

1659 Brainstem Implant (ABI) 2000

System

P000018/00M- Novoste Corp. Beta-CathTM System November 3,

1649 2000

P990036/00M- Cordis Corp. Cordis CheckmateTM November 3,

1650 System 2000

P990056/00M- Roche Elecsys Total November 22,

1660 Diagnostics, PSA Immunoassay and 2000

Corp. Calset

P990081/00M- Ventana Medical PathwayTM HER 2 November 28,

1661 Systems, Inc. 2000

P000027/00M- Roche Elecsys Free December 12,

1683 Diagnostics PSA Immunoassay/Calset/ 2000

Corp. Calcheck

P980020/00M- Q Care Q-103 Needle Management December 21,

1684 International, Systems 2000

LLC

------------------------------------------------------------------------

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.

Dated: March 1, 2001.

S. Kahan,

Deputy Director for Regulations Policy, Center for Devices and Radiological Health.

[FR Doc. 01-5954 Filed 3-9-01; 8:45 am]

BILLING CODE 4160-01-F

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...